Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia
Ruzmayuddin Mamat, Rusdi Abd Rashid, Baharudin Ibrahim, Suzaily Wahab, Azmir Ahmad, Maw Shin Sim
Journal of Addictive Diseases August 4, 2023 DOI: 10.1080/10550887.2023.2240932 via OpenAlex
Summary
AI-generated from the abstractPsilocybin use in vaping is increasing among amphetamine-type stimulant users and across broader populations, yet knowledge about its long-term health effects remains limited. The authors call for further research to highlight harmful effects and the potential risks of psilocybin vaping, especially among younger people.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Cannabis Psilocybin |
| Keywords | Medicine Hallucinogen Psychiatry |
| Citations | 2 |
| Key finding | Psilocybin vaping is growing among ATS users and across populations, but long-term health effects are poorly understood. |
Abstract
Psilocybin in vaping is growing among ATS users and across all populations. Unfortunately, knowledge regarding the long-term effects on health is limited. Further studies should highlight the harmful effects of psilocybin and the potential risk of psilocybin vaping among the younger population.